Department of Biomedical, Experimental and Clinical Sciences, Centre of Excellence DeNothe, University of Florence, Florence, Italy.
Hum Reprod. 2014 Mar;29(3):418-28. doi: 10.1093/humrep/det454. Epub 2014 Jan 15.
Does CatSper have a role in the achievement of human sperm motility and in the Progesterone (P)-induced acrosome reaction (AR)?
CatSper1 expression is associated with human sperm progressive motility and the P-induced AR; it may have a role in the pathogenesis of asthenozoospermia.
Knockout mice for any of the Catsper family genes fail to acquire hyperactivated motility and are infertile. CatSper channels mediate P-induced Ca(2+) influx in human sperm. The role of CatSper in human sperm hyperactivated/activated motility and in asthenospermia is less clear. A few men with CatSper mutations have been described but the phenotype regarding sperm motility has not been well established.
STUDY DESIGN, SIZE, DURATION: The effects of two Catsper inhibitors, NNC55-0396 (NNC, 10 and 20 µM) and Mibefradil (Mib, 30 and 40 µM), were tested on human sperm motility parameters and the P-induced AR. Catsper1 protein expression was evaluated in unselected and swim-up selected sperm samples and in sperm from normo- and astheno-zoospermic subjects.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Semen sample kinematic parameters were analysed by a CASA system. A fluorescent-labelled lectin was used to evaluate P-induced AR in live sperm by fluorescence microscopy. CatSper1 protein expression was determined by western blot analysis and by flow cytometry. Intracellular calcium concentrations ([Ca(2+)]i) were evaluated by a spectrofluorimetric method following sperm loading with the calcium-sensitive probe fura 2/AM.
CatSper1 protein was localized in the tail of human sperm. CatSperI expression was higher in swim up selected than unselected sperm both when measured by western blot or by flow cytometry (52.7 ± 15.8% versus 27.2 ± 9.01%, n = 7, P < 0.01). Basal and P-stimulated [Ca(2+)]i were significantly higher in swim-up selected compared with unselected sperm. CatSper1 expression (western blot analysis) was found to be decreased in sperm from asthenozoospermic (n = 10) compared with those from normozoospermic (n = 9) men (intensity values relative to β-actin: 244.4 ± 69.3 versus 385.8 ± 139.5, P < 0.01). A positive correlation was found between CatSper1 protein expression and the percentage of sperm with progressive motility (n = 19, r = 0.59, P = 0.007). NNC (10 µM) and Mib (30 µM) significantly reduced the percentage of sperm with progressive motility and several kinematic parameters but did not affect the percentage of hyperactivated sperm. Their effects were the same whether they were added to swim-up selected and capacitated sperm or were added to the swim-up medium. Mib was found to have a slight but significant effect on sperm viability at both concentrations tested. P-stimulated AR was significantly reduced by both inhibitors (P < 0.05). Overall, our results indicate that, in human sperm, CatSper channel expression and function are associated with progressive motility and may be involved in the pathogenesis of asthenozoospermia.
LIMITATIONS, REASONS FOR CAUTION: In general, studies evaluating the effect of inhibitors have the limitation of the specificity of the molecules. We show here that Mib may have toxic effect on human sperm. Although most of the parameters have been evaluated in live sperm, the toxic effect could have contributed to the observed decreases. More studies are necessary to evaluate further the role of CatSper1 in asthenozoospermia.
In view of the involvement in P-induced AR and of the evidence of a role in the pathogenesis of astenozoospermia, CatSper channels may represent a promising target for the development of new drugs for the treatment of male infertility and for non-hormonal contraception.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by grants from Ministry of University and Scientific Research (Prin project to E.B. and FIRB project to S.M) and Regione Toscana (to G.F.). The authors have no conflicts of interest to declare.
CatSper 在人类精子的运动能力和孕激素 (P) 诱导的顶体反应 (AR) 中是否发挥作用?
CatSper1 表达与人类精子的渐进性运动和 P 诱导的 AR 相关;它可能在弱精子症的发病机制中起作用。
任何 CatSper 家族基因的敲除小鼠都无法获得超激活运动能力,并且不育。CatSper 通道介导 P 诱导的人类精子中 Ca(2+) 内流。CatSper 在人类精子超激活/激活运动和弱精子症中的作用尚不清楚。已经描述了少数具有 CatSper 突变的男性,但精子运动能力的表型尚未得到很好的确定。
研究设计、规模、持续时间:测试了两种 CatSper 抑制剂 NNC55-0396(NNC,10 和 20 µM)和 Mibefradil(Mib,30 和 40 µM)对人类精子运动参数和 P 诱导的 AR 的影响。在未经选择和泳选的精子样本以及正常和弱精子症患者的精子中评估了 CatSper1 蛋白表达。
参与者/材料、设置、方法:通过 CASA 系统分析精液样本的运动参数。通过荧光显微镜使用荧光标记的凝集素评估活精子中 P 诱导的 AR。通过 Western blot 分析和流式细胞术确定 CatSper1 蛋白表达。通过荧光分光光度法评估精子负载钙敏感探针 fura 2/AM 后的细胞内钙浓度 ([Ca(2+)]i)。
CatSper1 蛋白定位于人类精子的尾部。泳选后选择的精子与未选择的精子相比,CatSperI 表达通过 Western blot 或流式细胞术更高(52.7 ± 15.8%对 27.2 ± 9.01%,n = 7,P < 0.01)。泳选后的精子与未选择的精子相比,基础和 P 刺激的 [Ca(2+)]i 明显更高。与正常精子症患者(n = 9)相比,弱精子症患者(n = 10)的精子中 CatSper1 表达(Western blot 分析)降低(相对于 β-肌动蛋白的强度值:244.4 ± 69.3 对 385.8 ± 139.5,P < 0.01)。发现 CatSper1 蛋白表达与具有渐进性运动的精子百分比之间存在正相关(n = 19,r = 0.59,P = 0.007)。NNC(10 µM)和 Mib(30 µM)显著降低了具有渐进性运动的精子百分比和几个运动参数,但不影响超激活精子的百分比。无论它们是添加到泳选后的精子中还是添加到泳选培养基中,它们的作用都是相同的。在两个测试浓度下,Mib 都发现对精子活力有轻微但显著的影响。两种抑制剂均显著降低 P 诱导的 AR(P < 0.05)。总的来说,我们的结果表明,在人类精子中,CatSper 通道的表达和功能与渐进性运动有关,可能与弱精子症的发病机制有关。
局限性、谨慎的原因:一般来说,评估抑制剂作用的研究具有分子特异性的局限性。我们在这里表明,Mib 可能对人类精子有毒性作用。尽管大多数参数都在活精子中进行了评估,但毒性作用可能导致了观察到的减少。需要进一步的研究来评估 CatSper1 在弱精子症中的作用。
鉴于 CatSper 通道在 P 诱导的 AR 中的作用以及在弱精子症发病机制中的证据,CatSper 通道可能成为开发用于治疗男性不育和非激素避孕的新药物的有前途的靶点。
研究资助/利益冲突:这项工作得到了意大利大学和科学研究部(Prin 项目给 E.B.和 FIRB 项目给 S.M)和托斯卡纳大区(给 G.F.)的资助。作者没有利益冲突需要声明。